ADC（Antibody-Drug Conjugate）

We provide compound screening and synthesis, process development for novel monomers, linkers, and ligands, as well as the development and production of novel, highly specific ADC linkers at any scale. See Further information for more about our ADC.

Services

Linker/toxin synthesis process and optimization
ADC process development
Intermediate and final API stability
Analysis of impurities
Analytical method development
Multiple formats of ADCs
Process characterization
Successful scale-up experiences from milligram to kilogram scale
Linker-Payload Chemical Synthesis
Linker-Payload Synthesis Pathway Design and Screening
Linker-Payload Purification and Process Development
Linker-Payload Analytical Method Development
Access to Extensive Linker and Payload Libraries
Support for Clinical Lead Synthesis Using Advanced Scalable Conjugation Techniques and Analytical Methods
Process Development, Optimization, and Scale-Up
Formulation Development (Liquid and Lyophilized) and Drug Development
Conjugation Process Design
Process and Analytical Method Development

Technical Advantages

Provide one-stop CDMO services from R&D to GMP commercial production of antibody coupling drugs, including coupling and purification process development and optimization, analysis development and optimization, naked antibody production, ADC stock solution production, ADC preparation production.
Integrated cost control program can reduce costs for partners, improve the affordability of biologic drugs, and be characterized by "flexibility" to build modular production process strategies according to different needs.
With excellent process and production technical team at home and abroad, to ensure technical advancement and production stability.